- $302.10m
- $333.15m
- $103.12m
Sanara Medtech Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Sanara MedTech Q3 Net Income USD -2.9 Million
Brief: Sanara Medtech Announces Changes To Its Board Of Directors
Sanara Medtech Inc reports results for the quarter ended in June - Earnings Summary
Brief: Sanara MedTech Q2 Net Income USD -3.5 Million
Sanara Medtech Inc expected to post a loss of 21 cents a share - Earnings Preview
Sanara Medtech Inc reports results for the quarter ended in March - Earnings Summary
Brief: Sanara Medtech Says CEO Zachary Fleming Delivered Notice To Board That He Is Resigning From His Position
Brief: Sanara MedTech Q1 Net Income USD -1.8 Million
Sanara Medtech Inc expected to post a loss of 7 cents a share - Earnings Preview
Sanara Medtech Inc reports results for the quarter ended in December - Earnings Summary
Brief: Sanara MedTech FY Net Income USD -4.4 Million
Sanara Medtech Inc expected to post a loss of 13 cents a share - Earnings Preview
Sanara Medtech Inc expected to post a loss of 13 cents a share - Earnings Preview
Brief: Sanara Medtech Inc. Announces Exclusive License Agreement For Patented Collagen Peptides
Brief: Sanara MedTech Q3 Net Income USD -1.1 Million
Sanara rises after first sale of bone graft product
Brief: Sanara Medtech Announces First Sale Of Allocyte® Plus Advanced Viable Bone Matrix And Provides Other Product Updates
Sanara Medtech Inc reports results for the quarter ended in June - Earnings Summary